{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:41:50Z","timestamp":1791513710035,"version":"4.3.4"},"reference-count":89,"publisher":"Informa UK Limited","issue":"2","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803355"],"award-info":[{"award-number":["81803355"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1080\/13543776.2024.2446222","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T10:36:13Z","timestamp":1735382173000},"page":"79-89","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["A patent review of xanthine oxidase inhibitors (2021\u2013present)"],"prefix":"10.1080","volume":"35","author":[{"given":"Chang","family":"Liu","sequence":"first","affiliation":[{"name":"Shenyang Pharmaceutical University","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Mao","sequence":"additional","affiliation":[{"name":"Shenyang Pharmaceutical University","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shenyang Pharmaceutical University","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Fu","sequence":"additional","affiliation":[{"name":"Shenyang Pharmaceutical University","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingjian","family":"Zhang","sequence":"additional","affiliation":[{"name":"China Medical University","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojie","family":"Wang","sequence":"additional","affiliation":[{"name":"Shenyang Pharmaceutical University","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867323666160725091915"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2009.11.012"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1530\/REP-19-0422"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2017.03.003"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2024.108615"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2009.00860.x"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22403"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/2040622315618393"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu197"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.899852"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209707"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2017.12.009"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00346-9"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199305040-00017"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2014.01.001"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.58.1.6"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.51847\/RkCPaycprc"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.132"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.5070\/D397D8T291"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409500102"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24209"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12392"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12391"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3474-8"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.01.060"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202400137"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.07.061"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2010.02.013"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.07.062"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.107042"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1039\/D4MD00072B"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2017.04.031"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/jhet.4796"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c01710"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389557517666170216142113"},{"key":"e_1_3_5_38_1","unstructured":"Wang S Zhao J Yang Y et al. Compound for inhibiting xanthine oxidase activity its preparation method and application in treatment and\/or prevention of hyperuricemia and gout. CN113004208. 2021."},{"key":"e_1_3_5_39_1","unstructured":"Wang S Zhao J Mao Q et al. 2-phenylpyrimidine-4-carboxylic acid derivative its preparation method pharmaceutical composition and application to drug for treatment and\/or prevention of hyperuricemia and gout. CN112979559. 2021."},{"key":"e_1_3_5_40_1","unstructured":"Wang S Zhao J Duan Y et al. Pyrimidopyrazole derivative for inhibiting xanthine oxidase activity its preparation method and application. CN112778318. 2021."},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.114086"},{"key":"e_1_3_5_42_1","unstructured":"Wang S Mao Q Zhao J. 2-(3-cyano-4-alkoxy)phenylpyrimidine derivative compound with xanthine oxidase inhibitory activity for treating and preventing hyperuricemia and gout and its preparation method. CN112209886. 2021."},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2021.116117"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103021"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2017.04.003"},{"key":"e_1_3_5_46_1","unstructured":"Meng F Tu S Zhang T et al. N-(indol-5-yl) aromatic heterocyclic amide compounds as xanthine oxidase inhibitors and their preparation pharmaceutical compositions and use in the treatment of hyperuricemia and gout. CN112920170. 2021."},{"key":"e_1_3_5_47_1","unstructured":"Meng F Zhang T Tu S et al. Preparation method of (indolyl)imidazolecarboxamide compounds as xanthine oxidase inhibitors and application thereof in preparation of drugs for resisting hyperuricemia and gout. CN112920169. 2021."},{"key":"e_1_3_5_48_1","unstructured":"Meng F Tu S Zhang T et al. N-(indol-5-yl)bicyclic arylamide its preparation method and application for treating gout diseases. CN112778316. 2021."},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/14786419.2021.2013212"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105417"},{"key":"e_1_3_5_51_1","unstructured":"Wang S Duan Y Yang Y. N-indole-1 6-dihydropyrimidine-4-carboxamide derivative used as xanthine oxidase inhibitor preparation and application in treatment or prevention of hyperuricemia and gout thereof. CN113173918. 2021."},{"key":"e_1_3_5_52_1","unstructured":"Wang S Yang Y. Duan Y 1-alkyl-5-tetrazolyl\/pyrimidinone-1H-indole-3-methylnitrile compounds and their preparation method and application in hyperuricemia and gout. CN113173917. 2021."},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113928"},{"key":"e_1_3_5_54_1","unstructured":"Liu G Li W Huang D et al. 5-(N-Substituted indol-5-yl)isoxazole-3-formic acid derivative as xanthine oxidase inhibitor and synthetic method and application thereof in prevention and\/or treatment of hyperuricemia and\/or gout. CN116283946. 2023."},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116443"},{"key":"e_1_3_5_56_1","unstructured":"Xiao Z Ye F Yang Y et al. Diaryl-1 2 4-triazole compounds their preparation methods and their use in drugs for the prevention and treatment of gout or diseases related to hyperuricemia. CN113354616. 2021."},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.106162"},{"key":"e_1_3_5_58_1","unstructured":"Xiao Z Ye F Cheng H et al. Preparation of hydroxy(alkoxyphenyl)pyrimidinecarbonitriles as xanthine oxidase inhibitors. CN116535361. 2023."},{"key":"e_1_3_5_59_1","unstructured":"Meng F Zhang Z Zhang T et al. Preparation method of N-phenyl aromatic formamide compound and its application in preparation of medicine for resisting hyperuricemia and gout. CN112898274. 2021."},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.105938"},{"key":"e_1_3_5_61_1","unstructured":"Li J Peng W Zhang L et al. Preparation of phenyltetrazolium compounds as XOR inhibitor for uric acid-lowering and gout treatment. CN114805233. 2022."},{"key":"e_1_3_5_62_1","unstructured":"Li J Zhu X Yang C et al. Preparation of nitrogen-substituted benzothiazolinone as XOR\/URAT1 dual inhibitor for prevention and treatment of diseases related to XOR\/URAT1. CN113087683. 2021."},{"key":"e_1_3_5_63_1","unstructured":"Li J Yang C Zhu X et al. Preparation of tricyclic XOR\/URAT1 dual inhibitor containing 2-hydroxybenzoic acid and its application in preparation of drug for treating hyperuricemia or gout. CN114805192. 2022."},{"key":"e_1_3_5_64_1","unstructured":"Liao Z. Wang M preparation method of anserine derivative from anserine and application thereof in preparation of xanthine oxidase (XOD) inhibitor or drugs for lowering uric acid. CN115677668. 2023."},{"key":"e_1_3_5_65_1","unstructured":"Shi D Fu C. Yang Y preparation of indazole or indole compounds as xanthine oxidase inhibitor. EP4335844. 2022."},{"key":"e_1_3_5_66_1","unstructured":"Lu G. Lu C Dipeptide capable of relieving hyperuricemia and regulating intestinal flora and application thereof. CN113004370. 2021."},{"key":"e_1_3_5_67_1","unstructured":"Wu X Zhang H. Wu H Tetrapeptide with activity of lowering uric acid and its application in preparing xanthine oxidase (XOD) inhibitor or preparing drugs or health foods for preventing hyperuricemia. CN116514905. 2023."},{"key":"e_1_3_5_68_1","unstructured":"Yu Z Cao Y Zhao W et al. Xanthine oxidase inhibiting peptide and application thereof in treating gout. CN113144169. 2021."},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.13437"},{"key":"e_1_3_5_70_1","unstructured":"Li Y Yu D Yang C et al. Use of isoliquiritigenol and 5 7-dihydroxy coumarin in the preparation of a medicament targeting xanthine oxidase for treating hyperuricemia or gout. CN117482080. 2024."},{"key":"e_1_3_5_71_1","unstructured":"Xu L Qiu Y Liu Y et al. Application of baicalin in the preparation of drugs for the prevention and\/or treatment of asymptomatic hyperuricemia and\/or uric acid nephropathy. CN112451537. 2021."},{"key":"e_1_3_5_72_1","unstructured":"Du G Zhou Q Yang H et al. Application of nepetin in preparation of drug for preventing and\/or treating hyperuricemia and\/or gout. CN114377005. 2022."},{"key":"e_1_3_5_73_1","unstructured":"Qiu S. Li X application of pharmaceutical composition-containing Cajanus cajan leaf extract and its monomer components in xanthine oxidase inhibitory drug preparation. CN115120579. 2022."},{"key":"e_1_3_5_74_1","unstructured":"Liao S He X Xu G et al. Application of caraphenol a in preparation of xanthine oxidase inhibiting drugs. CN113304140. 2021."},{"key":"e_1_3_5_75_1","unstructured":"Wang W Li Z Chen L et al. Application of punica granatum in preparation of xanthine oxidase inhibitors. CN117357544. 2024."},{"key":"e_1_3_5_76_1","unstructured":"He R Zou J Liang L et al. 2-(3\u2032 4\u2032-dihydroxyphenyl)-1 3-benzodioxole-5-carboxaldehyde and its preparation and application in inhibiting xanthine oxidase and uric acid. CN115350177. 2022."},{"key":"e_1_3_5_77_1","unstructured":"Xu X Wang X Cui W et al. Application of oridonin in preparing drugs for treating hyperuricemia and gout. CN112402410. 2021."},{"key":"e_1_3_5_78_1","unstructured":"Liu C Chen J Sun J et al. Preparation method of geniposide derivative with aldehydrase inhibiting activity and its application in preparation of medicine for reducing uric acid. CN114315929. 2022."},{"key":"e_1_3_5_79_1","unstructured":"Li M Zhang J Duan Y et al. Extraction of nitrogenophilic ketone compounds and its application in lowering uric acid. CN115650944. 2023."},{"key":"e_1_3_5_80_1","unstructured":"Shi B Liu J Ai H et al. Strictosidine derivatives and application in the preparation of drugs for inhibiting uric acid synthesis against gouty arthritis. CN114409715. 2022."},{"key":"e_1_3_5_81_1","unstructured":"Liu Y Lv X Gao X et al. Preparation method of sulfonyl fangchinoline compound applied to xanthine oxidase (XOD) inhibitor and drug for treating hyperuricemia. CN112250690. 2021."},{"key":"e_1_3_5_82_1","unstructured":"Gao B Qiao Z Han L et al. Method for extracting isoquercitrin in sunflower for preparation of xanthine oxidase inhibitor using column chromatography. CN112457357. 2021."},{"key":"e_1_3_5_83_1","unstructured":"Zhang W Xu L Li H et al. Application of Peniophora sp. A871 extract in preparation of medicine for treating gout. CN112553088. 2021."},{"key":"e_1_3_5_84_1","unstructured":"Chen F-A. Sung C-C lactobacillus plantarm bfa-la04 strain capable of lowering uric acid and application thereof. CN113493749. 2021."},{"key":"e_1_3_5_85_1","unstructured":"Cho C composition for ameliorating hyperuricemia comprising dendropanax morbifera extract. WO2021172678. 2021."},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)42428-9"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1080\/15257770802146577"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M208307200"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0400973101"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105417"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.134832"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2024.2446222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T04:06:02Z","timestamp":1738382762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2024.2446222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1080\/13543776.2024.2446222"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2024.2446222","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-09-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}